Christopher L. Shaffer

2.7k total citations
56 papers, 1.8k citations indexed

About

Christopher L. Shaffer is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Christopher L. Shaffer has authored 56 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 19 papers in Cellular and Molecular Neuroscience and 13 papers in Pharmacology. Recurrent topics in Christopher L. Shaffer's work include Neuroscience and Neuropharmacology Research (16 papers), Receptor Mechanisms and Signaling (12 papers) and Drug Transport and Resistance Mechanisms (8 papers). Christopher L. Shaffer is often cited by papers focused on Neuroscience and Neuropharmacology Research (16 papers), Receptor Mechanisms and Signaling (12 papers) and Drug Transport and Resistance Mechanisms (8 papers). Christopher L. Shaffer collaborates with scholars based in United States, Netherlands and Sweden. Christopher L. Shaffer's co-authors include Chandra Prakash, Angus Nedderman, Shawn Harriman, R. Scott Obach, Robert P. Hanzlik, Amit S. Kalgutkar, Abdul Mutlib, Deepak Dalvie, Iain Gardner and Yasuhiro Nakai and has published in prestigious journals such as Journal of the American Chemical Society, Biological Psychiatry and Brain Research.

In The Last Decade

Christopher L. Shaffer

55 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher L. Shaffer United States 23 780 386 357 286 233 56 1.8k
Claire Mackie Belgium 25 793 1.0× 371 1.0× 490 1.4× 216 0.8× 189 0.8× 49 2.0k
Stephen E. Clarke United Kingdom 22 701 0.9× 344 0.9× 926 2.6× 403 1.4× 284 1.2× 42 2.3k
Y. Nancy Wong United States 19 657 0.8× 171 0.4× 344 1.0× 239 0.8× 328 1.4× 38 2.0k
Dennis O. Scott United States 26 638 0.8× 223 0.6× 488 1.4× 560 2.0× 209 0.9× 51 2.1k
Jukka Gynther Finland 27 650 0.8× 339 0.9× 267 0.7× 171 0.6× 351 1.5× 73 1.7k
Krista Laine Finland 26 602 0.8× 310 0.8× 364 1.0× 569 2.0× 178 0.8× 44 2.1k
Bindi Sohal United Kingdom 19 608 0.8× 466 1.2× 221 0.6× 101 0.4× 389 1.7× 38 1.5k
L. P. C. Delbressine Netherlands 19 422 0.5× 143 0.4× 297 0.8× 306 1.1× 261 1.1× 39 1.7k
A. E. Medvedev Russia 25 959 1.2× 307 0.8× 97 0.3× 184 0.6× 286 1.2× 152 1.9k
Maria João Bonifácio Portugal 21 605 0.8× 360 0.9× 123 0.3× 208 0.7× 169 0.7× 85 1.7k

Countries citing papers authored by Christopher L. Shaffer

Since Specialization
Citations

This map shows the geographic impact of Christopher L. Shaffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher L. Shaffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher L. Shaffer more than expected).

Fields of papers citing papers by Christopher L. Shaffer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher L. Shaffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher L. Shaffer. The network helps show where Christopher L. Shaffer may publish in the future.

Co-authorship network of co-authors of Christopher L. Shaffer

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher L. Shaffer. A scholar is included among the top collaborators of Christopher L. Shaffer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher L. Shaffer. Christopher L. Shaffer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shaffer, Christopher L., et al.. (2025). Objective real-world mobility patterns in Parkinson's disease: Driving and walking after levodopa dosing. Parkinsonism & Related Disorders. 140. 108055–108055.
2.
Shaffer, Christopher L., et al.. (2024). Quantitative effects of sleep‐disrupting medications on real‐world sleep metrics in older adults at risk for neurodegeneration. Alzheimer s & Dementia. 20(S3). e089806–e089806. 1 indexed citations
3.
4.
Podany, Anthony T., Parvez Κhan, Christopher L. Shaffer, et al.. (2023). Chemotherapy in pediatric brain tumor and the challenge of the blood–brain barrier. Cancer Medicine. 12(23). 21075–21096. 7 indexed citations
5.
Loryan, Irena, Andreas Reichel, Bo Feng, et al.. (2022). Unbound Brain-to-Plasma Partition Coefficient, Kp,uu,brain—a Game Changing Parameter for CNS Drug Discovery and Development. Pharmaceutical Research. 39(7). 1321–1341. 62 indexed citations
6.
Shaffer, Christopher L., et al.. (2017). Insights from mathematical modeling for convection-enhanced intraputamenal delivery of GDNF. Medical & Biological Engineering & Computing. 55(12). 2069–2077. 4 indexed citations
7.
Shah, Falgun, Antonia F. Stepan, Alison O’Mahony, et al.. (2017). Mechanisms of Skin Toxicity Associated with Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators. Cell chemical biology. 24(7). 858–869.e5. 26 indexed citations
8.
Blokland, Arjan, Nick P. van Goethem, Christopher L. Shaffer, et al.. (2015). PDE5 inhibition improves acquisition processes after learning via a central mechanism. Neuropharmacology. 97. 233–239. 20 indexed citations
9.
Uthayathas, Subramaniam, Christopher L. Shaffer, Frank S. Menniti, Christopher J. Schmidt, & Stella M. Papa. (2013). Assessment of adverse effects of neurotropic drugs in monkeys with the “Drug Effects on the Nervous System” (DENS) scale. Journal of Neuroscience Methods. 215(1). 97–102. 8 indexed citations
10.
Harvey, Brian D., Chester J. Siok, Tamás Kiss, et al.. (2013). Neurophysiological signals as potential translatable biomarkers for modulation of metabotropic glutamate 5 receptors. Neuropharmacology. 75. 19–30. 16 indexed citations
11.
Rutten, Kris, Sven Akkerman, Arjan Blokland, et al.. (2012). Phosphodiesterase type 5 (PDE5) inhibition improves object recognition memory: Indications for central and peripheral mechanisms. Neurobiology of Learning and Memory. 97(4). 370–379. 53 indexed citations
12.
Mao, Li-Min, Christopher L. Shaffer, Ming‐Lei Guo, et al.. (2011). Reversible Palmitoylation Regulates Surface Stability of AMPA Receptors in the Nucleus Accumbens in Response to Cocaine In Vivo. Biological Psychiatry. 69(11). 1035–1042. 34 indexed citations
13.
Wager, Travis T., Anabella Villalobos, Patrick R. Verhoest, Xinjun Hou, & Christopher L. Shaffer. (2011). Strategies to optimize the brain availability of central nervous system drug candidates. Expert Opinion on Drug Discovery. 6(4). 371–381. 32 indexed citations
14.
Chatterjee, Susmita, Pia Steensland, Jeffrey A. Simms, et al.. (2010). Partial Agonists of the α3β4* Neuronal Nicotinic Acetylcholine Receptor Reduce Ethanol Consumption and Seeking in Rats. Neuropsychopharmacology. 36(3). 603–615. 90 indexed citations
15.
Shaffer, Christopher L., Mithat Gunduz, Alfin D. N. Vaz, Karthik Venkatakrishnan, & Aaron H. Burstein. (2008). Metabolism and Disposition of a γ-Aminobutyric Acid Type A Receptor Partial Agonist in Humans. Drug Metabolism and Disposition. 36(4). 655–662. 3 indexed citations
16.
Prakash, Chandra, Christopher L. Shaffer, & Angus Nedderman. (2007). Analytical strategies for identifying drug metabolites. Mass Spectrometry Reviews. 26(3). 340–369. 216 indexed citations
17.
Shaffer, Christopher L., Mithat Gunduz, Renato J. Scialis, & Annie Fang. (2007). Metabolism and Disposition of a Selective α7 Nicotinic Acetylcholine Receptor Agonist in Humans. Drug Metabolism and Disposition. 35(7). 1188–1195. 22 indexed citations
18.
Shaffer, Christopher L., Mithat Gunduz, Bruce A. Thornburgh, & Gwendolyn D. Fate. (2006). Using a Tritiated Compound to Elucidate Its Preclinical Metabolic and Excretory Pathways in Vivo: Exploring Tritium Exchange Risk. Drug Metabolism and Disposition. 34(9). 1615–1623. 22 indexed citations
19.
Shaffer, Christopher L., Mithat Gunduz, Thomas N. O’Connell, R. Scott Obach, & Shiyin Yee. (2005). BIOTRANSFORMATION OF A GABAA RECEPTOR PARTIAL AGONIST IN SPRAGUE-DAWLEY RATS AND CYNOMOLGUS MONKEYS: IDENTIFICATION OF TWO UNIQUE N-CARBAMOYL METABOLITES. Drug Metabolism and Disposition. 33(11). 1688–1699. 29 indexed citations
20.
Shaffer, Christopher L., et al.. (2001). A Multicenter Evaluation of Gentamicin Therapy in the Neonatal Intensive Care Unit. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 21(1). 7–10. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claire Mackie Breakdown of academic impact, for papers by Stephen E. Clarke Breakdown of academic impact, for papers by Y. Nancy Wong Breakdown of academic impact, for papers by Dennis O. Scott Breakdown of academic impact, for papers by Jukka Gynther Breakdown of academic impact, for papers by Krista Laine Breakdown of academic impact, for papers by Bindi Sohal Breakdown of academic impact, for papers by L. P. C. Delbressine Breakdown of academic impact, for papers by A. E. Medvedev Breakdown of academic impact, for papers by Maria João Bonifácio
Rankless by CCL
2026